Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Luken Investment Analytics »

Ligand Pharmaceuticals In shares owned by Luken Investment Analytics

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Luken Investment Analytics from 13F filings

Historical chart of Luken Investment Analytics investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Luken Investment Analytics consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Luken Investment Analytics

Quarter filed	Position value	Share count	Share price at filing
2023-12-31	$3.6k	50	71.42
2023-09-30	$3.0k	50	59.92
2023-06-30	$7.2k	100	72.10
2023-03-31	$7.4k	100	73.56
2022-12-31	$6.7k	100	66.80
2020-12-31	$10k	100	100.00

More positions owned by Luken Investment Analytics

First Tr Exchange-traded Ft Vest Tec (TDVI)

First Tr Exchange-traded Ft Vest Gold (IGLD)

Spdr Series Trust Portfolio S&p500 (SPLG)

Spdr Index Shs Fds Portfolio Emg Mk (SPEM)

First Tr Exchange-traded Ft Vest Ris (RDVI)

Ssga Active Tr Spdr Blackstone (HYBL)

Invesco Qqq Tr Unit Ser 1 (QQQ)

First Tr Exchng Traded Fd Vi Ft Vest Int June (YJUN)

Spdr S&p 500 Etf Tr Tr Unit (SPY)

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)

First Tr Exchange-traded First Tr Enh New (FTSM)

Ishares Tr Core S&p500 Etf (IVV)

First Tr Exch Traded Fd Iii Ft Vest Smid (SDVD)

Spdr Index Shs Fds Portfolio Devlpd (SPDW)

Ssga Active Etf Tr Blackstone Senr (SRLN)

View all positions for Luken Investment Analytics

Top funds holding Ligand Pharmaceuticals In

Henderson Group

Macquarie Group

State Street Corporation

Chicago Capital

Stephens Investment Management Group

Dimensional Fund Advisors

Massachusetts Financial Services

Congress Asset Management

Geode Capital Management

Loomis, Sayles and

Ubs Global Asset Management Americas

View all funds holding Ligand Pharmaceuticals In

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z